{
  "ticker": "ATX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02974520",
  "id": "02974520",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250730",
  "time": "1251",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250730/pdf/06m9wl0rv8y5cm.pdf",
  "summary": "### **Form 604 \u2013 Notice of Change of Interests of Substantial Holder**  \n**Company:** Amplia Therapeutics Limited (ASX: ATX)  \n**Substantial Holder:** Acorn Capital Limited  \n\n#### **Key Changes in Holdings:**  \n- **Previous Voting Power (as of last notice):** 7.43% (34,573,696 shares)  \n- **Current Voting Power (as of this notice):** 8.91% (36,144,321 shares)  \n- **Net Increase:** **1.57% (1,570,625 shares)** acquired between 16/06/2025 and 19/06/2025.  \n\n#### **Detailed Purchases:**  \n- **16/06/2025:** Bought **908,009 shares** at ~$0.066/share ($59,902.48 total).  \n- **17/06/2025:** Bought **3,250,235 shares** at ~$0.071/share ($231,719.62 total).  \n- **18/06/2025:** Bought **901,568 shares** at ~$0.079/share ($71,616.65 total).  \n- **19/06/2025:** Bought **1,070,625 shares** at ~$0.157/share ($168,452.65 total).  \n- **04/07/2025:** **500,000 shares** acquired (consideration not disclosed).  \n- **Effect of Dilution (29/07/2025):** Adjustments made due to new issuance (impact not quantified).  \n\n#### **Relevance:**  \n- **Increased stake by a substantial holder (Acorn Capital)** suggests confidence or strategic accumulation.  \n- **Dilution event noted but no details on issuance size/pricing** \u2013 monitor for future capital structure changes.   \n\n**Final Note:** No trading halt, capital raising, or financial operational updates\u2014pure ownership change disclosure.",
  "usage": {
    "prompt_tokens": 1384,
    "completion_tokens": 407,
    "total_tokens": 1791,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-30T03:28:50.877456"
}